Patents by Inventor Yehong WANG

Yehong WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REDUCTION IN ACETATE PRODUCTION BY YEAST OVER-EXPRESSING MIG3
    Publication number: 20230002793
    Abstract: Described are compositions and methods relating to modified yeast that over-express MIG transcriptional regulator polypeptides. The yeast produces a deceased amount of acetate compared to parental cells. Such yeast is particularly useful for large-scale ethanol production from starch substrates where acetate in an undesirable end product.
    Type: Application
    Filed: November 24, 2020
    Publication date: January 5, 2023
    Inventors: MIN QI, QUINN QUN ZHU, JAMIE YEHONG WANG
  • DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS
    Publication number: 20220144910
    Abstract: The invention relates to methods, uses, and compositions (e.g., articles of manufacture and kits) for preventing or treating graft versus host disease (GVHD) (e.g., acute or chronic GVHD, including corticosteroid-refractory acute GVHD).
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Matthew KALO, Timothy Then-Chioh LU, Melicent Clare PECK, Siddharth SUKUMARAN, Yehong WANG, Chin Yat WONG, Peter William DAY
  • DOSING FOR TREATMENT WITH IL-22 Fc FUSION PROTEINS
    Publication number: 20210139552
    Abstract: The invention relates to methods, uses, and compositions (e.g., articles of manufacture and kits) for the treatment of diseases associated with IL-22 (e.g., inflammatory bowel disease (IBD) (e.g., ulcerative colitis (UC (e.g., moderate to severe UC)) and Crohn's disease (CD)) and graft versus host disease (GVHD) (e.g., acute or chronic GVHD)).
    Type: Application
    Filed: August 20, 2020
    Publication date: May 13, 2021
    Inventors: Matthew KALO, Timothy Then-Chioh LU, Siddharth SUKUMARAN, Yehong WANG, Peter William DAY
  • DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS
    Publication number: 20210023176
    Abstract: The invention relates to methods, uses, and compositions (e.g., articles of manufacture and kits) for preventing or treating graft versus host disease (GVHD) (e.g., acute or chronic GVHD, including corticosteroid-refractory acute GVHD).
    Type: Application
    Filed: July 24, 2020
    Publication date: January 28, 2021
    Inventors: Matthew KALO, Timothy Then-Chioh LU, Melicent Clare PECK, Siddharth SUKUMARAN, Yehong WANG, Chin Yat WONG, Peter William DAY